Fortrea
Mark Morais currently serves as the COO and President of Clinical Services at Fortrea, a position held since July 2023. Previously, Mark held multiple leadership roles at Labcorp Drug Development from September 2020 to July 2023, including COO and President of Labcorp Clinical Development, as well as President of Clinical Operations and Commercial Solutions. Mark's experience also includes serving as SVP of Strategic Deal Development at Covance from June 2017 to September 2020, and various roles at QuintilesIMS from 2001 to 2017, culminating in Vice President positions in Global Business Operations and Clinical Pricing Services. Mark Morais earned a Bachelor of Science degree in Economics from North Carolina State University between 1994 and 1999.
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.